ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 29 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,286,425 | -3.7% | 1,413,809 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $1,336,332 | -1.3% | 1,413,809 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $1,353,722 | +6.4% | 1,413,809 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1,272,428 | -73.3% | 1,413,809 | -32.9% | 0.00% | -78.9% |
Q3 2022 | $4,763,000 | +6.4% | 2,107,595 | +18.6% | 0.02% | 0.0% |
Q2 2022 | $4,477,000 | +1.5% | 1,776,744 | +18.4% | 0.02% | +5.6% |
Q1 2022 | $4,410,000 | -12.0% | 1,500,000 | +50.0% | 0.02% | -10.0% |
Q4 2021 | $5,010,000 | +28.6% | 1,000,000 | +100.0% | 0.02% | +17.6% |
Q3 2021 | $3,895,000 | – | 500,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Syncona Portfolio Ltd | 11,086,909 | $55,545,000 | 53.06% |
RA Capital Management | 5,014,687 | $25,124,000 | 0.44% |
Artal Group S.A. | 2,255,375 | $11,299,000 | 0.31% |
Redmile Group, LLC | 2,088,089 | $10,461,000 | 0.24% |
Orbimed Advisors | 1,584,845 | $7,940,000 | 0.10% |
Sender Co & Partners, Inc. | 27,690 | $139,000 | 0.07% |
Baker Brothers Advisors | 2,591,366 | $12,983,000 | 0.06% |
Perceptive Advisors | 1,510,750 | $7,568,000 | 0.06% |
Woodline Partners LP | 324,387 | $1,625,000 | 0.02% |
Point72 Asset Management, L.P. | 1,000,000 | $5,010,000 | 0.02% |